An AMCP Webinar, presented by FormularyDecisions.

Managed care organizations and biopharmaceutical companies today are reimagining how to deliver sustained value and protect future innovation amid significant health policy changes. Key areas that will be covered in this upcoming AMCP webinar will include:

• Mapping the latest policy updates - ranging from manufacturer negotiations on drug pricing to government directives aimed at lowering health insurance costs.
• Forecasting potential future impacts for stakeholders in managed care pharmacy and the biopharmaceutical industry to empower informed decision-making and enhance patient support.
• Sharing real-world insights on how organizations are adapting to current and forecasted policy changes.

An AMCP Webinar.

Artificial intelligence is beginning to reshape how medicine is practiced and more specifically how medications are prescribed, reviewed, and monitored - and Utah is one of the first states to pilot an AI-enabled prescribing model at scale. In this webinar, Dr. Byron Crowe of Doctronic will provide a high-level overview of the Utah AI prescribing pilot, explaining how the model works in practice and what it could mean for the future of medication management.

Designed for managed care pharmacists, the session will explore how AI is being used to support clinical decision-making at the point of prescribing, including how patient data, clinical guidelines, and safety checks are integrated into the workflow. Dr. Crowe will also discuss the governance, oversight, and regulatory considerations that shaped the pilot, as well as early lessons learned around safety, quality, and provider adoption.

The webinar will conclude with a forward-looking discussion on where AI-enabled prescribing is headed - implications for utilization management, formulary strategy, prior authorization, and the evolving role of pharmacists in an AI-supported care model.

An AMCP Precision Medicine LINK Group Webinar.

The AMCP Precision Medicine initiative continues its work to advance evidence-based access and informed coverage decisions across managed care. In this session, LINK leaders will share updates on ongoing initiatives, foundational coverage work, and what's on the horizon for precision medicine.

Dana McCormick will open the discussion with an overview of current AMCP Precision Medicine activities and the value-focused topic areas guiding this work. Steve Kheloussi will provide a concise overview of the emerging coverage principles designed to support consistent, transparent, and clinically grounded decision-making. Sheetal Sheth will conclude with a look ahead at the precision medicine pipeline and what payers should be watching next. This webinar is designed for managed care pharmacists and payer stakeholders seeking a clear view of where precision medicine efforts stand today - and where they are headed.

An AMCP Webinar.

AMCP is launching the Health Disparities LINK, a new member‑driven community created to turn insight into action across managed care pharmacy. Building on the foundational learnings from AMCP’s 2024 Health Disparities Symposium and key reflections from 2025, this kickoff session explores why inequities persist in access, quality, and outcomes—and how themes from “The Education Gap is the Equity Gap: Using Data and SDOH to Empower Smarter Health Decisions: Where Analytics Meet Awareness—and Knowledge Becomes Care” help frame the pathway forward.

This session will highlight how disparities rooted in health literacy, information access, and social determinants of health (SDOH) shape real‑world decision‑making, and how payers can leverage data, analytics, and targeted interventions to promote equitable care and coverage. Attendees will gain insight into the Health Disparities LINK’s 2026 focus areas, early workstreams, and opportunities to contribute case examples, tools, and best practices.

An AMCP Market Insights Webinar Rebroadcast.

This webinar will provide an overview of the prevalence, pathology, and disease management of Mucopolysaccharidosis (MPS), a group of ultra-rare inherited metabolic disorders for which there is currently no cure. Panelists will share key insights and findings from AMCP’s Market Insights Roundtable, The Role of Managed Care in Improving Patient Care in Mucopolysaccharidosis.

Artificial intelligence is driving profound change across the global economy and healthcare, reshaping how work is done, value is created, and decisions are made. In this webinar, Harry Travis, BS Pharm, MBA, will examine AI’s broad economic impact before narrowing the focus to healthcare and, ultimately, pharmacy and managed care pharmacy. He will highlight where AI is already improving workflows, automation, and decision‑making, and where realistic near‑term opportunities and risks exist—helping pharmacy leaders better understand how to navigate AI adoption beyond the hype.

A Science & Innovation Webinar, presented by Eisai.

Advances in Alzheimer's disease (AD) diagnostics are reshaping clinical practice, making early and precise detection possible. Explore the latest clinical insights related to blood-based biomarkers, which include their importance in AD and appropriate utilization for patient care.

A Pre-Approval Information Exchange (PIE) Webinar, presented by Sanofi.

Join us for an engaging discussion on multiple myeloma treatment and isatuximab subcutaneous administration via on-body injector (Isa SC OBI). We'll explore the key attributes of the Isa SC OBI device, including preparation and administration protocols. The session will review clinical evidence from the IRAKLIA trial demonstrating non-inferiority between Isa IV and Isa SC OBI, as well as findings from the IZALCO trial investigating Isa SC OBI vs. manual push administration.

This webinar is only offered to payers, formulary committees, or other similar entities
responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product has not been established.

A Science & Innovation Webinar, presented by Abbvie.

Alopecia Areata is more than a cosmetic hair loss concern. It is a chronic, autoimmune disease characterized by unpredictable, non-scarring hair loss that can affect the scalp, face, and body. While its most visible manifestation is hair loss, AA reflects underlying immune dysregulation that may extend beyond hair loss. If left untreated or poorly managed, AA can be associated with a range of comorbidities—including Systemic Lupus Erythematosus (SLE), vitiligo, and atopic dermatitis. The psychosocial toll of AA, which may include anxiety, depression, PTSD, stress, social stigma, and social withdrawal, compounds the disease burden and can adversely impact patient outcomes and quality of life.